Clinical Neuroscience Review Branch – CN

Dr. Sulagna Banerjee

Chief

Review Branch Summary

The Clinical Neuroscience (CN) Review Branch is led by Dr. Sulagna Banerjee. CN reviews grant applications that have neural disorders and/or injury of the nervous system as their main focus. Investigations appropriate for review in the CN Review Branch may include those using animal models of neural injury or disease or specific aspects of the diseases or disorders, investigations based on the study of specific patient populations, or investigations focused on the development of rehabilitative and therapeutic strategies. Specific areas of interest include the investigations of traumatic brain or spinal cord injury, abnormal brain development and function, epilepsy, the consequences of episodes of ischemia or hypoxia, vascular cognitive impairment, demyelinating disorders, as well as studies of mental disorders, brain tumors, CNS infections, and neuropathies. These specific areas of interest may be studied from the perspective of neuroanatomical or neurophysiological alterations, changes in neurotransmitter or neurotrophin function or metabolism, the genetic, cellular, or molecular basis of alterations induced by disease or injury, the influence or involvement of the immune or vascular systems or neuroinflammation in a neural disease process or response, and the neurological basis of addictive, cognitive, behavioral, and emotional disorders.

Study Sections

 

 

Last updated: 06/14/2024 12:10